A qualitative evaluation of volunteers' experiences in a phase I/II HIV vaccine trial in Tanzania
Open Access
- 24 October 2011
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 11 (1) , 283
- https://doi.org/10.1186/1471-2334-11-283
Abstract
Evaluating experiences of volunteers in an HIV vaccine trial will be useful for the conduct of future trials. The purpose of this study among volunteers who participated in a phase I/II HIV vaccine trial in Dar es Salaam, Tanzania was to assess what characterized their experiences during the trial.Keywords
This publication has 19 references indexed in Scilit:
- Reasons for Declining to Enroll in a Phase I and II HIV Vaccine Trial after Randomization among Eligible Volunteers in Dar es Salaam, TanzaniaPLOS ONE, 2011
- Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, TanzaniaBMC Public Health, 2010
- P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVARetrovirology, 2009
- Strengths and Challenges in the Use of Interpretive Description: Reflections Arising From a Study of the Moral Experience of Health Professionals in Humanitarian WorkQualitative Health Research, 2009
- Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, TanzaniaGlobal Health Action, 2009
- Social impact of preventive HIV vaccine clinical trial participation: A model of prevention, assessment and interventionSocial Science & Medicine, 2008
- What should South African HIV vaccine trials do about social harms?AIDS Care, 2007
- Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccineCMAJ : Canadian Medical Association Journal, 2005
- Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, ThailandAIDS, 2004
- Safety and Immunogenicity of a Canarypox‐Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher‐ and Lower‐Risk VolunteersThe Journal of Infectious Diseases, 2001